Skip to main content
Skip to navigation

All Committee for Human Medicinal Products articles

Journal
Key steps and considerations of the EU centralised procedure

2019-07-01T14:19:00Z

This continuing professional development article aims to provide some of the background and key steps and considerations when using and navigating the EU centralised procedure for a new marketing authorisation application (MAA).